Published 6 days ago • loading... • Updated 6 days ago

WHO Urges Rapid Treatment for Concurrent HIV and Mpox

Recommendations for patients with both conditions reflect broader guidance for ART.

9 Articles

Is this the beginning of the end of HIV/AIDS? Lenacapavir “o...

Is this the beginning of the end of HIV/AIDS? Lenacapavir “offers 100% protection” against contracting HIV and there are already 6 generic manufacturers lined up to produce the drug under royalty-free licensing agreements.

6 days ago

Read Full Article

Medscape

WHO Urges Rapid Treatment for Concurrent HIV and Mpox

Recommendations for patients with both conditions reflect broader guidance for ART.

6 days ago·United States

Read Full Article

pharmaceutical-technology.com

Gilead wins positive European approval opinion for twice-yearly HIV injection - Pharmaceutical Technology

The European Medicines Agency’s CHMP has recommended approval of Gilead Sciences’ lenacapavir, a twice-yearly injection for preventing HIV infection.

6 days ago

Read Full Article

Science-et-vie.com

Two Injections a Year Against Hiv: Will This Revolutionary New Treatment Make the Virus Disappear?

For more than forty years, the fight against HIV has progressed to the rhythm of major scientific discoveries and logistical or social setbacks. Despite the existing treatments, the virus is still circulating actively in many regions, fueled by inequalities in access to care and difficulties of adherence to daily protocols. In this contrasting landscape, the emergence of preventive treatment for HIV administered in two annual injections upsets p…

6 days ago

Read Full Article

Živě.cz

Almost 100% Hiv Prevention Has Already Been Approved in Europe. Just Two Injections a Year Are Enough

Twice-yearly lenacapavir protects against HIV with exceptional efficacy • This injectable prevention replaces daily use of previously required tablets • Key authorities approve the drug, licensing ensures its global availability and impact

6 days ago

Read Full Article

lindependant.fr

Reposted by

La-R%C3%A9publique-des-Pyr%C3%A9n%C3%A9es

Hiv: Europe Gives Green Light to Prep for Injection Every 6 Months

The European Medicines Agency has recommended on Friday the use of lenacapavir in the tools available in the fight against HIV. Presented as "a decisive step forward" by the WHO, it is a treatment...

6 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year